Search

Home > New FDA Approvals > 068 - FDA strengthens public warning and notification of recalls; FDA’s compounding policy priorities plan; Qiagen expanded use of EGFR CDx for afatinib
Podcast: New FDA Approvals
Episode:

068 - FDA strengthens public warning and notification of recalls; FDA’s compounding policy priorities plan; Qiagen expanded use of EGFR CDx for afatinib
Category: Science & Medicine
Duration: 00:09:22
Publish Date: 2018-01-19 07:00:00
Description:

January 19, 2018 

Please tell your colleagues asbout this podcast! Just tell them to "go to the newfdaapprovals.com website” - thank you!

0:53  FDA statement on strengthening public warning and notification of recalls

https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm592777.htm

3:05 FDA’s 2018 Compounding Policy Priorities Plan https://www.fda.gov/NewsEvents/Newsroom/FDAInBrief/ucm592610.htm

5:18 Qiagen Gets FDA OK for Expanded Use of EGFR CDx for afatinib https://corporate.qiagen.com/newsroom/press-releases/2017/20180118_therascreen_egfr

7:15 Medical writing Nascentmc.com
Total Play: 0